Abstract:
The objective of this experiment is to identify the combination of RDT and conditional (diagnosisdependent) ACT subsidies that maximize the percent of clients receiving an RDT. We will test
two different RDT price levels and two discounted ACT price levels in a factorial design. ACT
discounts are conditional on a positive RDT result. The primary outcome measure is the decision
to purchase an RDT before purchasing a drug. Secondary outcome measures are: Decision to
purchase an ACT stratified by testing status: (a.) Positive mRDT (b.) Negative mRDT (c.) No
malaria test. All outcomes will be measured by interviewing the participant after they make their
decision about whether to be tested and which medicines to purchase.